Interview with James Hanlon, CEO, Clonmel Healthcare
Mr. Hanlon, can you please begin by introducing Clonmel Healthcare to our readers? Clonmel Healthcare was founded by an Irish family in the 1970’s. During this time, its primary goal…
Address: Waterford Road, Clonmel, Co. Tipperary,Ireland
Tel: 052 617 7777
Web: http://www.clonmel-health.ie/professional/
In 2006 Clonmel Healthcare embarked on a brand redevelopment strategy following the findings of a major customer research report commissioned by the company. In early 2007 the new corporate identity was launched. The new distinctive brand mark represents Clonmel Healthcare’s core values of quality, customer service and dynamism and retains the strength of our heritage and strong link to our Irish roots.
Clonmel Healthcare currently has a large portfolio of products covering three distinct business units; Prescription medicines, Speciality medicines and the ClonMedica Consumer Division. Our prescription products cover a wide range of therapeutic areas including CNS, cardiovascular, NSAID, gastro-intestinal and anti-infectives. Within the Special Products Division we have medicines for the treatment of Parkinson’s disease, Testosterone Deficiency Syndrome and the management of diabetes. The ClonMedica product range focuses on three main areas; women’s and babies health, skincare and health supplements.
Mr. Hanlon, can you please begin by introducing Clonmel Healthcare to our readers? Clonmel Healthcare was founded by an Irish family in the 1970’s. During this time, its primary goal…
Mr. Somers, can you please introduce us to the Helsinn Group and its unique in-licensing model? Helsinn is a Swiss-based, private company owned by the Braglia family. The Braglias have…
Mr. Hanlon, can you please begin by introducing Clonmel Healthcare to our readers? Clonmel Healthcare was founded by an Irish family in the 1970’s. During this time, its primary goal…
Mr. Hynds, you were personally instrumental in leading the establishment of Actavis in Ireland in 2008. You commented at the time, ‘Historically, Actavis grew by acquisition in other markets, but…
Mr. Martin, you were appointed as Genzyme’s GM for UK and Ireland last month after having spent a decade at the organization. Robin Kenselaar, Head of Genzyme EMEA, noted that…
Ms. Dickens, in our interview with your Sanofi colleague Jan Hendrix in Belgium last month, he commented that it is amazing how diversified this company has become in just the…
Can you give us a sense of the history of this company and its Irish roots? The company started life in the UK and has always been a GI franchise…
Mr. Looney, what has it been like to run this business for 26 years? Looking back, what can you say that you have built? It has certainly been an exciting…
Dr. Coveney, what motivated you to start this company? I had been working for the multinationals for a number of years—Schering Plough, and a number of other organizations. In 1999,…
In 2008, MSD began building a human vaccine facility in Carlow—a 220MN EUR investment that the company expanded upon last year with an additional 7Mn EUR. What is the importance…
This interview also features the comments of Geraldine Murphy, Managing Director of Leo Pharma, Ireland. Ms. Murphy, your transition to your current position was precipitated by a major refocusing that…
This interview also features the comments of Brendan Fitzpatrick, Vice President Finished Goods Manufacturing. Ms. Murphy, your transition to your current position was precipitated by a major refocusing that LEO…
Mr. O’Leary, when an article in The Guardian last year profiled you and your work, it was titled “Resurrecting the Celtic Tiger.” More recently, Time Magazine put Taoiseach Enda Kenny…
See our Cookie Privacy Policy Here
